Patents Represented by Attorney, Agent or Law Firm Patrick M. Ryan
  • Visible light absorbers for ophthalmic lens materials
    Patent number: 8329775
    Abstract: Azo compounds that block visible light are disclosed. These light absorbers are particularly suitable for use in intraocular lens materials.
    Type: Grant
    Filed: January 18, 2011
    Date of Patent: December 11, 2012
    Assignee: Novartis AG
    Inventor: Walter R. Laredo
  • Topical nepafenac formulations
    Patent number: 8324281
    Abstract: Topical suspension compositions of nepafenac are disclosed. The compositions are especially suitable for topical ophthalmic administration.
    Type: Grant
    Filed: October 5, 2011
    Date of Patent: December 4, 2012
    Assignee: Novartis AG
    Inventor: Warren Wong
  • UV-absorbers for ophthalmic lens materials
    Patent number: 8323631
    Abstract: Dihydroxybenzotriazole UV absorbing compounds that are particularly useful in ophthalmic devices are disclosed.
    Type: Grant
    Filed: July 19, 2011
    Date of Patent: December 4, 2012
    Assignee: Novartis AG
    Inventor: David L. Jinkerson
  • Ophthalmic and otorhinolaryngological device materials containing a reactive NVP macromer
    Patent number: 8293858
    Abstract: Disclosed are soft, high refractive index, acrylic device materials. The materials contain a reactive macromer based on N-vinyl pyrrolidone.
    Type: Grant
    Filed: January 14, 2010
    Date of Patent: October 23, 2012
    Assignee: Novartis AG
    Inventor: Walter R. Laredo
  • UV/visible light absorbers for ophthalmic lens materials
    Patent number: 8262947
    Abstract: Benzotriazole UV/Visible light-absorbing monomers are disclosed. The UV/Vis absorbers are particularly suitable for use in intraocular lens materials.
    Type: Grant
    Filed: July 2, 2010
    Date of Patent: September 11, 2012
    Assignee: Novartis AG
    Inventor: Walter R. Laredo
  • 2-amino benzophenone UV-absorbers for ophthalmic lens materials
    Patent number: 8236053
    Abstract: Ophthalmic device materials comprising 2-amino benzophenone UV-absorbing compounds are disclosed. The ophthalmic device materials are particularly useful in intraocular lenses.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: August 7, 2012
    Assignee: Novartis AG
    Inventor: Charles Freeman
  • UV/visible light absorbers for ophthalmic lens materials
    Patent number: 8232326
    Abstract: Benzotriazole UV/Visible light-absorbing monomers are disclosed. The UV/Vis absorbers are particularly suitable for use in intraocular lens materials.
    Type: Grant
    Filed: February 8, 2012
    Date of Patent: July 31, 2012
    Assignee: Novartis AG
    Inventor: Walter R. Laredo
  • Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
    Patent number: 8211880
    Abstract: Triamcinolone acetonide suspension compositions are disclosed. The suspension compositions have a relatively low viscosity and are easy to extrude through a 27- or 30-guage needle but are highly flocculated and easily redispersed. The compositions are particularly suitable for intravitreal injection.
    Type: Grant
    Filed: January 17, 2012
    Date of Patent: July 3, 2012
    Assignee: Alcon Research, Ltd.
    Inventors: Bhagwati P. Kabra, Ruma Sarkar
  • Visible light absorbers for ophthalmic lens materials
    Patent number: 8207244
    Abstract: Azo compounds that block visible light are disclosed. These light absorbers are particularly suitable for use in intraocular lens materials.
    Type: Grant
    Filed: July 2, 2010
    Date of Patent: June 26, 2012
    Assignee: Novartis AG
    Inventor: Walter R. Laredo
  • Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate
    Patent number: 8173671
    Abstract: Topical ophthalmic and otic solution compositions of moxifloxacin and dexamethasone phosphate are disclosed.
    Type: Grant
    Filed: December 14, 2010
    Date of Patent: May 8, 2012
    Assignee: Alcon Research, Ltd.
    Inventors: Onkar N. Singh, Suresh C. Dixit, Michael Wall
  • Ophthalmic and otorhinolaryngological device materials
    Patent number: 8163862
    Abstract: Disclosed are soft, high refractive index, acrylic device materials. The materials contain a hydrophilic side-chain macromer for glistening resistance.
    Type: Grant
    Filed: June 29, 2011
    Date of Patent: April 24, 2012
    Assignee: Novartis AG
    Inventor: Douglas C. Schlueter
  • UV/visible light absorbers for ophthalmic lens materials
    Patent number: 8153703
    Abstract: Benzotriazole UV/Visible light-absorbing monomers are disclosed. The UV/Vis absorbers are particularly suitable for use in intraocular lens materials.
    Type: Grant
    Filed: November 3, 2009
    Date of Patent: April 10, 2012
    Assignee: Novartis AG
    Inventor: Walter R. Laredo
  • Ophthalmic and otorhinolaryngological device materials containing a multi-arm PEG macromer
    Patent number: 8148445
    Abstract: Disclosed are soft, high refractive index, acrylic device materials. The materials contain a multi-arm PEG macromer.
    Type: Grant
    Filed: January 14, 2010
    Date of Patent: April 3, 2012
    Assignee: Novartis AG
    Inventor: Walter R. Laredo
  • Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
    Patent number: 8128960
    Abstract: Triamcinolone acetonide suspension compositions are disclosed. The suspension compositions have a relatively low viscosity and are easy to extrude through a 27- or 30-gauge needle but are highly flocculated and easily redispersed. The compositions are particularly suitable for intravitreal injection.
    Type: Grant
    Filed: March 10, 2009
    Date of Patent: March 6, 2012
    Assignee: Alcon Research, Ltd.
    Inventors: Bhagwati P. Kabra, Ruma Sarkar
  • Dual function UV-absorbers for ophthalmic lens materials
    Patent number: 8119830
    Abstract: Disclosed are UV absorbers that contain a labile functional group capable of initiating free radical polymerization.
    Type: Grant
    Filed: March 11, 2010
    Date of Patent: February 21, 2012
    Assignee: Novartis AG
    Inventor: Douglas C. Schlueter
  • UV-absorbers for ophthalmic lens materials
    Patent number: 8115009
    Abstract: 1,4-disubstituted-1,2,3-triazole UV absorbing monomers are disclosed. The UV absorbers are particularly suitable for use in intraocular lens materials.
    Type: Grant
    Filed: January 11, 2011
    Date of Patent: February 14, 2012
    Assignee: Novartis AG
    Inventor: Douglas C. Schlueter
  • Ophthalmic and otorhinolaryngological device materials containing an alkyl ethoxylate
    Patent number: 8105378
    Abstract: Disclosed are soft, high refractive index, acrylic device materials. The materials contain a functionalized alkyl ethoxylate to reduce glistenings.
    Type: Grant
    Filed: October 1, 2008
    Date of Patent: January 31, 2012
    Assignee: Novartis AG
    Inventor: Water R. Laredo
  • Topical nepafenac formulations
    Patent number: 8071648
    Abstract: Topical suspension compositions of nepafenac are disclosed. The compositions are especially suitable for topical ophthalmic administration.
    Type: Grant
    Filed: September 23, 2010
    Date of Patent: December 6, 2011
    Assignee: Novartis AG
    Inventor: Warren Wong
  • Low-tack ophthalmic and otorhinolaryngological device materials
    Patent number: 8058323
    Abstract: Disclosed are soft, high refractive index, acrylic materials. These materials, especially useful as intraocular lens materials, contain one or more aryl acrylic hydrophobic monomers as principal device-forming monomers and a tack-reducing macromer additive. In addition to their use as intraocular lens materials, the present materials are also suitable for use in other ophthalmic or otorhinolaryngological devices, such as contact lenses, keratoprostheses, corneal inlays or rings; otological ventilation tubes and nasal implants.
    Type: Grant
    Filed: January 23, 2009
    Date of Patent: November 15, 2011
    Assignee: Novartis AG
    Inventors: Diana M. Cordova, Mutlu Karakelle, Chance Lehman, Douglas C. Schlueter, Joseph I. Weinschenk, III
  • Ophthalmic and otorhinolaryngological device materials
    Patent number: 8048154
    Abstract: Disclosed are soft, high refractive index, acrylic device materials. The materials contain a hydrophilic side-chain macromer for glistening resistance.
    Type: Grant
    Filed: October 3, 2008
    Date of Patent: November 1, 2011
    Assignee: Novartis AG
    Inventor: Douglas C. Schlueter